FDA Inspection 1182395 — AngioSystems Inc
The FDA completed an inspection of AngioSystems Inc on September 1, 2022 in Ducktown, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 1, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Ducktown, TN (United States)